Tanaka K, Tanaka M, Miyatake T, Yamamoto A, Kurahashi K, Matsunaga M
Department of Neurology, Niigata University, Japan.
Tohoku J Exp Med. 1987 Oct;153(2):161-7. doi: 10.1620/tjem.153.161.
The serum IgG of a 50-year-old woman with lung cancer associated with subacute cerebellar degeneration and Lambert-Eaton myasthenic syndrome showed the antibody activity to rat brain proteins. Using an immunoblotting method, the patient serum reacted with 98 kDa neutral cytoplasmic protein and 68 kDa membrane protein. These proteins were different in molecular weight from those we described previously (Tanaka et al. 1986), which suggests that proteins reacting with serum antibody are variable individually among patients with subacute cerebellar degeneration. These proteins from human brain could not be stained by the patient's serum IgG since these antigen proteins needed to be prepared quickly after death under protease inhibitors and were thought to be easily degraded.
一名50岁患肺癌且伴有亚急性小脑变性和兰伯特-伊顿肌无力综合征的女性患者的血清IgG显示出对大鼠脑蛋白的抗体活性。采用免疫印迹法,患者血清与98 kDa中性细胞质蛋白和68 kDa膜蛋白发生反应。这些蛋白质的分子量与我们之前描述的(田中等人,1986年)不同,这表明在亚急性小脑变性患者中,与血清抗体反应的蛋白质个体之间存在差异。由于这些抗原蛋白需要在蛋白酶抑制剂存在的情况下于死后迅速制备,且被认为容易降解,因此患者血清IgG无法对来自人脑的这些蛋白质进行染色。